Doses start at 0.25 mg weekly, increasing every 4 weeks until reaching a maintenance dose of 2.4 mg weekly, if tolerated
Together, these actions: Increase insulin release only when blood glucose is elevated Reduce excess glucose production by the liver Slow stomach emptying, limiting post-meal glucose spikes Act on appetite centres in the brain, increasing fullness and reducing hunger Because insulin release is glucose-dependent, Mounjaro on its own has a low risk of causing hypoglycaemia (low blood sugar), unless combined with insulin or sulfonylurea medications
Our team serves patients in Bend, Oregon, Seattle, Washington, and through telehealth in Oregon, Washington, and California, providing expert guidance throughout the weight loss journey
Nudnoci, biegunka, niestrawno i ble brzucha to typowe dziaania niepodane, ktre wystpuj zwykle na pocztku leczenia i przemijaj po kilku lub kilkunastu dniach od rozpoczcia terapii [1,2]